Background-It is unknown whether modest increases of fibrin D-dimer, a circulating marker of fibrin turnover, are relevant to coronary heart disease (CHD) in the general population. Methods and Results-We measured serum concentrations of D-dimer antigen in the stored baseline blood samples of 630 CHD cases and 1269 controls "nested" in a prospective cohort of 5661 men who were monitored for 16 years, and we conducted a meta-analysis of previous relevant studies to place our findings in context. In a comparison of men in the top third compared with those in the bottom third of baseline fibrin D-dimer values (tertile cutoffs, Ͼ94 versus Ͻ49 ng/mL), the odds ratio for CHD was 1.67 (95% CI, 1.31 to 2.13; PϽ0.0001) after adjustments for age and town. The odds ratio increased slightly after further adjustment for smoking, other classic risk factors, and indicators of socioeconomic status (1.79; 95% CI, 1.36 to 2.36). Strong correlations were observed of fibrin D-dimer values with circulating concentrations of C-reactive protein and serum amyloid A protein but not with smoking, blood lipids, blood pressure, and other risk factors. Conclusion-Although there may be an association between circulating D-dimer values and CHD, further studies are needed to determine the extent to which this is causal.
C
irculating concentrations of fibrin D-dimer reflect the extent of fibrin turnover in the circulation, as this antigen is present in several degradation products from the cleavage of cross-linked fibrin by plasmin. 1, 2 Highly elevated D-dimer values occur in various disorders in which the coagulation system is excessively activated, such as acute venous thromboembolism. 3 It has been suggested that modestly elevated circulating D-dimer values reflect minor increases in blood coagulation, thrombin formation, and turnover of crosslinked intravascular fibrin (which is partly intra-arterial in origin) and that these increases may be relevant to coronary heart disease (CHD). 2 We report the largest and most prolonged study thus far relating baseline values of D-dimer to subsequent CHD, and we report a meta-analysis of previous relevant studies to place our findings in context.
Methods
From 1978 to 1980, 7735 men aged 40 to 59 years (response rate, 78%) were randomly selected from general practice registers in each of 24 British towns and entered into the British Regional Heart Study. 4 Nurses administered questionnaires, made physical measurements, recorded an ECG, and, in 5661 men in 18 of the towns, collected nonfasting venous blood samples, from which serum was stored at Ϫ20°C for subsequent analysis. 4 All men have been monitored subsequently for all-cause mortality and for cardiovascular morbidity, with a follow up loss of Ͻ1% to date. 5 The present 643 cases included 279 CHD deaths and 364 cases of nonfatal myocardial infarction occurring between 1978 and 1996 (comprising cases reported in 2 previous studies). 6, 7 Fatal cases were ascertained through National Health Service Central Registers (death certificates with ICD-9 codes 410 to 414); the diagnosis of nonfatal myocardial infarction was based on reports from general practitioners, supplemented by regular reviews of general practice records, and diagnosis was in accordance with World Health Organization criteria. 8 A total of 1278 controls "frequency matched" to cases on town of residence and age in 5-year bands were randomly selected from among men who had survived to the end of the study period free from incident CHD. D-dimer measurements were available for 630 of these cases and 1269 of these controls.
Laboratory workers who were blinded to case-control status measured serum concentrations of D-dimer using a sensitive enzyme immunoassay, 9 lished data); these data were used to estimate the magnitude of regression dilution and to correct for it. 12 We prespecified case-control analyses by thirds of D-dimer values in controls, involving unmatched stratified logistic regression fitted by unconditional maximum likelihood (STATA Corporation). For associations between D-dimer and a variety of known and suspected risk factors, emphasis was mainly given to differences more extreme than 2.6 SD (2-tailed PϷ0.01) to make some allowance for multiple comparisons. A meta-analysis was conducted of prospective studies of D-dimer and CHD with Ͼ1 year of follow-up published before 2000 using methods described previously. 12 Cases were compared only with controls within the same studies to avoid potential biases.
Results

Present Prospective Study
There were highly significant differences between cases and controls with respect to various known vascular risk factors and D-dimer (Table 1) . Among controls, significant associations were observed of baseline D-dimer values with circulating concentrations of C-reactive protein and serum amyloid A protein but not with classic risk factors or serum markers of inflammation or infection (Table 2) . In a comparison of men in the top third compared with those in the bottom third of baseline D-dimer values (tertile cutoffs, Ͼ94 versus Ͻ49 ng/mL), the odds ratio (OR) for CHD was 1.67 (95% CI, 1.31 to 2.13; 2-tailed PϽ0.0001) after adjustments for age and town (Table 3) . The OR increased slightly after further adjustment for smoking, other vascular risk factors, and indicators of socioeconomic status (OR, 1.79; 95% CI, 1.36 to 2.36). An analysis restricted to the 407 cases and 1010 controls without baseline evidence of CHD yielded an adjusted OR of 1.43 (95% CI, 1.04 to 1.98), which was not significantly different from the OR for all cases and all controls ( 2 1 ϭ0.9;PϾ0.1).
Meta-Analysis of Previous Prospective Studies
Six previous prospective studies of D-dimer (including 4 studies in the general population 9,11,13,14 and 2 studies in cohorts defined on the basis of a history of peripheral vascular disease 15 and myocardial infarction 16 ) were identified. They involved a total of 905 CHD cases ( Figure 1 ) and had a mean weighted age at entry of 63 years and a mean weighted follow-up of 5 years. All studies used enzyme-linked immunoassays and adjusted for smoking, blood pressure, and blood cholesterol; only 2 studies also adjusted for plasma fibrinogen concentration. 9, 13 Together with the present study, the 7 available prospective studies included 1535 CHD cases, and there was no significant heterogeneity among them ( Values are meanϮSD or n (%). FC indicates fluorescent count. Adjustments for social class were omitted in the regressions involving markers of socioeconomic status. t ϩ tests were derived from regression of Log 10 D-dimer values on each characteristic, separately adjusting for age and town only. t ϩϩ tests were derived from regression of Log 10 D-dimer values adjusting for age, town, smoking, body mass index, and markers of socioeconomic status (including height). *PϽ0.01. 
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Discussion
This prospective, community-based study is the first to demonstrate a clearly significant association between baseline concentrations of D-dimer antigen and CHD that seems largely independent of classic risk factors. These findings are reinforced by a meta-analysis of 6 smaller prospective studies. Collectively, these studies suggest that CHD risk is Ϸ70% greater in those in the top third of D-dimer values compared with those in the bottom third ( Figure 2 ). Even so, the causal relevance of D-dimer to CHD remains uncertain. The present study was unable to assess the effect of adjusting for plasma fibrinogen concentration, but previous studies have reported only modest correlations between D-dimer and plasma fibrinogen values (for example, rϷ0.20) 9, 13, 17 and little reduction in the strength of association between D-dimer and CHD after correction for baseline plasma fibrinogen. 9, 13 It has also been suggested that D-dimer values may reflect inflammatory states, 2 and in the present study there were significant associations of D-dimer values with two circulating markers of inflammation but not with clinical evidence of CHD at baseline. Conversely, the possibility that D-dimer values predict prothrombotic states is suggested by preliminary associations with venous thrombosis and other conditions (such as atrial fibrillation) associated with intracardiac thrombosis and embolism 18 -20 and the rapid normalization of D-dimer values after cardioversion 19 or warfarinization 20 in patients with atrial fibrillation.
Conclusions
Although there may be an association between circulating D-dimer values and CHD, further studies are needed to determine the extent to which this is causal. Prospective studies of fibrin D-dimer and coronary heart disease including the present study.
